Hong Kong: IntelliCentrics sets IPO guidance

Healthcare technology platform IntelliCentrics Global plans to raise up to HK$582m (US$74m) in its Hong Kong IPO. It intends to sell 80.9m shares, or 18% of the enlarged share capital, at an indicative price range of HK$5.32-HK$7.19 per share. This would give the company a market capitalisation of up to US$413m. The deal is expected…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »